194 related articles for article (PubMed ID: 20724129)
21. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
Kast A; Hauser SP
Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
[TBL] [Abstract][Full Text] [Related]
22. Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy.
Joly F; Espié M; Marty M; Héron JF; Henry-Amar M
Br J Cancer; 2000 Sep; 83(5):577-82. PubMed ID: 10944595
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the cellular and humoral immune responses of tumor patients by mistletoe therapy.
Stein G; Henn W; von Laue H; Berg P
Eur J Med Res; 1998 Apr; 3(4):194-202. PubMed ID: 9533928
[TBL] [Abstract][Full Text] [Related]
24. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
25. Patients are talking about ... Iscador (mistletoe).
Decker G
Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
[TBL] [Abstract][Full Text] [Related]
26. Mistletoe and cancer: controversies and perspectives.
Mansky PJ
Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
[TBL] [Abstract][Full Text] [Related]
27. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
[TBL] [Abstract][Full Text] [Related]
28. Influence of postoperative complementary treatment with lectin-standardized mistletoe extract on breast cancer patients. A controlled epidemiological multicentric retrolective cohort study.
Schumacher K; Schneider B; Reich G; Stiefel T; Stoll G; Bock PR; Hanisch J; Beuth J
Anticancer Res; 2003; 23(6D):5081-7. PubMed ID: 14981970
[TBL] [Abstract][Full Text] [Related]
29. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
30. Mistletoe in conventional oncological practice: exemplary cases.
Legnani W
Integr Cancer Ther; 2008 Sep; 7(3):162-71. PubMed ID: 18956494
[TBL] [Abstract][Full Text] [Related]
31. Safety of high-dose intravenous mistletoe therapy in pediatric cancer patients: A case series.
Zuzak TJ; Wasmuth A; Bernitzki S; Schwermer M; Längler A
Complement Ther Med; 2018 Oct; 40():198-202. PubMed ID: 30219449
[TBL] [Abstract][Full Text] [Related]
32. [Mistletoe therapy in cancer treatment: pros and cons].
Wiebelitz KR; Beer AM; Heinrich B
MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
[No Abstract] [Full Text] [Related]
33. [Mistletoe in the treatment of cancer patients].
Rostock M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
[TBL] [Abstract][Full Text] [Related]
34. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.
Enesel MB; Acalovschi I; Grosu V; Sbarcea A; Rusu C; Dobre A; Weiss T; Zarkovic N
Anticancer Res; 2005; 25(6C):4583-90. PubMed ID: 16334146
[TBL] [Abstract][Full Text] [Related]
35. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
Melzer J; Iten F; Hostanska K; Saller R
Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
[TBL] [Abstract][Full Text] [Related]
37. Weight gain and quality of life in women treated with adjuvant chemotherapy for early-stage breast cancer.
McInnes JA; Knobf MT
Oncol Nurs Forum; 2001 May; 28(4):675-84. PubMed ID: 11383182
[TBL] [Abstract][Full Text] [Related]
38. Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapy.
Navari RM; Brenner MC; Wilson MN
Breast Cancer Res Treat; 2008 Nov; 112(1):197-201. PubMed ID: 18064563
[TBL] [Abstract][Full Text] [Related]
39. Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
Buijs C; Rodenhuis S; Seynaeve CM; van Hoesel QG; van der Wall E; Smit WJ; Nooij MA; Voest E; Hupperets P; TenVergert EM; van Tinteren H; Willemse PH; Mourits MJ; Aaronson NK; Post WJ; de Vries EG
J Clin Oncol; 2007 Dec; 25(34):5403-9. PubMed ID: 18048822
[TBL] [Abstract][Full Text] [Related]
40. Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
Steigenberger C; Schnell-Inderst P; Flatscher-Thöni M; Plank LM; Siebert U
Eur J Oncol Nurs; 2023 Aug; 65():102338. PubMed ID: 37321128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
